Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7679164rdf:typepubmed:Citationlld:pubmed
pubmed-article:7679164lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7679164lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:7679164lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:7679164lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:7679164lifeskim:mentionsumls-concept:C1524081lld:lifeskim
pubmed-article:7679164lifeskim:mentionsumls-concept:C0587107lld:lifeskim
pubmed-article:7679164pubmed:issue2lld:pubmed
pubmed-article:7679164pubmed:dateCreated1993-3-10lld:pubmed
pubmed-article:7679164pubmed:abstractTextPhysical effort stimulates the reninangiotensin system (RAS). We studied the effect of an angiotensin-converting enzyme inhibitor (ACE inhibitor) in a double-blind placebo-controlled study, on eight volunteers undergoing physical stress on an ergometric bicycle. The effects of captopril (C) (50 mg, three times daily for 3 days) on arterial pressure (AP), O2 consumption (VO2), variations in auricular natriuretic factor (ANF), renin, angiotensin II (AII) plasma levels, as well as glomerular filtration rate (GFR) and microalbuminuria (MA) were evaluated. The different parameters were compared by analysis of variance (ANOVA). The pressure profile and VO2 were not modified by ACE inhibitor. Exercise stimulates release of renin; this action was greater with captopril administration (treatment effect: p < 10(-4), indicating blockade of the RAS. This inhibition was incomplete because AII levels increased markedly when captopril was given (no treatment effect: p < 0.37). Finally, ACE inhibitor resulted in decreased GFR (p = 115 +/- 5.8 ml/mn-1, C = 91.1 +/- 4, p < 0.05) with exercise without modification of MA. ACE inhibitor administration does not modify the physical performance of nonathletic subjects; AII is significantly increased with exercise despite captopril treatment; ACE inhibitor decreases GFR significantly but does not influence MA with prolonged physical effort.lld:pubmed
pubmed-article:7679164pubmed:languageenglld:pubmed
pubmed-article:7679164pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7679164pubmed:citationSubsetIMlld:pubmed
pubmed-article:7679164pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7679164pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7679164pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7679164pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7679164pubmed:statusMEDLINElld:pubmed
pubmed-article:7679164pubmed:monthFeblld:pubmed
pubmed-article:7679164pubmed:issn0160-2446lld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:Leroux-Robert...lld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:HuangHHlld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:GalenF XFXlld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:AldigierJ CJClld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:ChassainA PAPlld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:DalmayFFlld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:BaussantTTlld:pubmed
pubmed-article:7679164pubmed:authorpubmed-author:LartigueMMlld:pubmed
pubmed-article:7679164pubmed:issnTypePrintlld:pubmed
pubmed-article:7679164pubmed:volume21lld:pubmed
pubmed-article:7679164pubmed:ownerNLMlld:pubmed
pubmed-article:7679164pubmed:authorsCompleteYlld:pubmed
pubmed-article:7679164pubmed:pagination289-95lld:pubmed
pubmed-article:7679164pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:meshHeadingpubmed-meshheading:7679164-...lld:pubmed
pubmed-article:7679164pubmed:year1993lld:pubmed
pubmed-article:7679164pubmed:articleTitleAngiotensin-converting enzyme inhibition does not suppress plasma angiotensin II increase during exercise in humans.lld:pubmed
pubmed-article:7679164pubmed:affiliationGirers, Laboratoire de Physiologie UFR Pharmacie, Limoges, France.lld:pubmed
pubmed-article:7679164pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7679164pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:7679164pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:7679164pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7679164lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7679164lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7679164lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7679164lld:pubmed